MedPage Today on MSN
Amputation risk in diabetes drops with GLP-1 drugs, study suggests
Association driven by fewer major amputations ...
Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers ...
Those taking GLP-1s had small but significant reductions in their 10-year chances of vertebral fractures, suggesting that the ...
A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.
Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...
Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how to protect your strength while reaping the benefits. Study: Glucagon-like peptide-1 receptor ...
In A Nutshell Metformin, a common diabetes medication costing less than $10 monthly, was linked to 37% fewer cases of progression to intermediate macular degeneration over five years. The study ...
Low cholesterol can reduce the risk of dementia, a new University of Bristol-led study with more than a million participants has shown. The research, led by Dr. Liv Tybjærg Nordestgaard while at the ...
A study found that drugs used to treat gout can also cut the chances of a potentially deadly heart attack and stroke. The ...
Epilepsy clinicians who also specialize in women’s health and work with women during the perinatal period can consult with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results